Laparoscopic resection for rectal adenocarcinoma.

Area of Science:

• Surgical Oncology
• Minimally Invasive Surgery
• Rectal Cancer Treatment

Background:

• Laparoscopic surgery for rectal cancer is debated, but evidence suggests feasibility and safety.
• Minimal access surgery offers potential benefits in rectal cancer treatment.

Purpose of the Study:

• To confirm laparoscopic resection for rectal cancer yields favorable recurrence rates and survival.
• To evaluate the safety and efficacy of laparoscopic rectal cancer surgery.

Main Methods:

• 252 patients underwent laparoscopic resection (LAR or LAPR) between 1998-2007.
• 48 patients received neoadjuvant radiochemotherapy (nCRT) for stage II/III mid-low rectal cancer.
• Data on recurrence, survival, complications, and treatment response were collected.

Main Results:

• 5-year survival was 73.7% with a 4.0% local recurrence rate.
• Neoadjuvant treatment led to downstaging in 40 patients, with 6 complete responses.
• Conversion to laparotomy occurred in 9.5% of cases; no nCRT patients required conversion.

Conclusions:

• Laparoscopic resection for rectal cancer is feasible and safe.
• Morbidity and long-term results are acceptable, including for patients receiving neoadjuvant therapy.
• Minimal access surgery is a viable option for rectal cancer treatment.